Coping With Asthma Throughout Life Management Program

Sponsor
Duke University
Study ID
NCT07044388
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Coping with asthma through life management program — BEHAVIORAL
    Participants will complete surveys, learn stress coping strategies, receive asthma education information, and obtain access local community financial resources.
  • Waitlist Control (CALM) — BEHAVIORAL
    Participants in this group will complete surveys but will not receive the CALM intervention. Upon completing the study after 12 weeks they will be able to complete the program if they would like the resources/materials to learn healthy stress coping strategies, asthma health education, and access to financial resources.

Study Details

The purpose of this study is to determine if the Coping with Asthma through Life Management (CALM) intervention, designed to help Black adult with asthma cope with stress, is feasible and acceptable.

Key Dates

First listed
Jul 1, 2025
Start date
Jun 15, 2026
Status verified
Aug 2025
Primary completion
Jul 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Randomized
    Group will receive intervention method
  • Other: Waitlist Control Group
    Participants will receive no intervention (control) during the trial. However, after the study is completed, they will have the option to receive intervention.

Primary Outcome Measure

Feasibility of Intervention Measure (FIM) [ Time Frame: 12 weeks ]

Central Contacts

Find similar trials

Nationwide
Asthma trialsPulmonology trialsLung disease trials

Related Studies